We are not taking full advantage of the HPV vaccine. Here's why
Researchers’ findings support broadening HPV vaccine coverage and increasing surveillance in the male population. Image: REUTERS/Lucy Nicholson
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Health and Healthcare
Listen to the article
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Health and HealthcareSee all
Mary Hui
July 14, 2023
Argyro Avgoustaki and Hans Frankort
July 13, 2023
Lesley Ndlovu
July 12, 2023
Seth Berkley and Etleva Kadilli
July 11, 2023
Thomas Crampton and Rob Blackie
July 11, 2023
Simon Torkington
July 11, 2023